Polpharma outlines growth strategy for newly acquired Romanian pharmaceutical firm Biofarm

Polpharma's regional director Tamás Uri confirmed the company's intent to aggressively scale operations at the Bucharest-based Biofarm facility following its acquisition. The strategy focuses on regional expansion within Central and Eastern Europe, though specific investment figures and production targets remain undisclosed.